Why Is Nutanix (NTNX) Up 15.7% Since Last Earnings Report?

Nutanix (NTNX) reported strong fourth-quarter fiscal 2025 results, with non-GAAP EPS of $0.37, beating estimates by 15.63% and growing 60.8% year-over-year, alongside revenues of $653.3 million, up 19% and exceeding consensus. The company also surpassed its operating margin guidance, achieving 18.3%, driven by a 19% increase in subscription revenues to $616 million and a 17% rise in annual recurring revenue to $2.22 billion. Following these results, NTNX shares have risen 15.7%, outperforming the S&P 500; however, analyst estimates have recently trended downward, leading to a Zacks Rank #3 (Hold) despite positive FY26 revenue and free cash flow guidance.

Analysis

Nutanix demonstrated significant operational strength in its fourth-quarter fiscal 2025 results, outperforming consensus estimates on both revenue and earnings. Revenue grew 19% year-over-year to $653.3 million, while non-GAAP earnings per share surged 60.8% to $0.37. The performance was driven by the continued success of its subscription model, with subscription revenues climbing 19% and Annual Recurring Revenue (ARR) increasing 17% to $2.22 billion. Notably, the company achieved substantial margin expansion, with the non-GAAP operating margin reaching 18.3%, a 540 basis point improvement year-over-year that surpassed the company's own guidance. This profitability is supported by strong free cash flow of $207.8 million for the quarter. Despite this robust performance and a positive outlook for fiscal 2026—projecting revenues up to $2.94 billion and operating margins expanding to 21-22%—there is a notable disconnect with recent analyst activity. The article highlights that analyst estimates have seen a downward trend post-earnings, culminating in a Zacks Rank #3 (Hold). This is further complicated by mixed factor scores, with a strong 'A' for Growth but a weak 'F' for Value, indicating the stock's appeal may be limited to growth-focused investors after its 15.7% rally.

Key Decisions for Investors

• Given the strong growth metrics and significant margin expansion, growth-oriented investors may find the positive operational momentum and robust company guidance for fiscal 2026 compelling.
• Investors should closely monitor the divergence between the company's strong guidance and the recent downward revisions in analyst estimates, as this could signal either a market overreaction or an underlying concern not yet reflected in company forecasts.
• With the stock's recent 15.7% outperformance and an 'F' grade for value, value-conscious investors should exercise caution, as the current valuation may already reflect the strong quarterly performance.
• Pay attention to future billings growth, which at 8% in Q4 lagged revenue growth of 19%, as this could be a leading indicator of future top-line deceleration.